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Abstract
Nonparasitic hepatic cysts constitute a heterogeneous group of disorders. A proper
diagnosis  of  hepatic  cyst  is  necessary in order  to  adopt  the best  treatment.  The
term hepatic cyst usually refers to simple hepatic cysts. Nonparasitic hepatic cysts
are also linked to genetic  disorders such as polycystic  liver disease (PLD) with/
without autosomal dominant polycystic kidney disease (ADPKD) or Caroli disease.
Generally, patients with nonparasitic hepatic cysts less than 3 cm are asymptomat‐
ic.  These  cysts  become  symptomatic  when  are  large,  multiple,  or  complicated.
Percutaneous  abdominal  ultrasound  is  the  best  imaging  modality  to  diagnose
hepatic cysts but must be completed by other imaging and serological tests. It is
important to differentiate simple hepatic cyst from hydatid cyst, cystadenoma, and
cystadenocarcinoma  before  proceeding  with  the  treatment.  Sometimes  the
diagnosis is very challenging. Asymptomatic single liver cysts need only surveil‐
lance,  but  symptomatic  and  complicated  ones  require  therapeutic  intervention.
Percutaneous aspiration of the cyst under ultrasound guidance is a mini-invasive
procedure generally associated with sclerotherapy. The highest success rates were
reported  for  laparoscopic  or  open  cyst  fenestration.  Liver  transplantation  is
indicated for patients with severe PLD.
Keywords: Simple hepatic cyst, serous hepatic cyst, nonparasitic hepatic cyst, poly‐
cystic liver disease
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
1. Introduction
Nonparasitic hepatic cysts encompass a heterogeneous group of disorders, which differ in
etiology, prevalence, and manifestations. The term hepatic cyst usually refers to solitary
nonparasitic cysts of the liver, also known as simple cysts. Generally, hepatic cysts are
incidentally found during surgery and more frequently during imaging examinations for other
reasons. Nowadays, due to the imaging procedures, prevalence of nonparasitic hepatic cysts
is found increased up to 18% in adult population [1]. The incidence is higher in females older
than 50 years.
2. Classification and etiology
2.1. Serous/simple hepatic cyst
Hepatic serous or simple cysts may be single or multiple and are considered to be congenital.
They are derived from aberrant bile ducts that have apparently lost communication with the
biliary tree and continue to secrete intramural fluid [2]. Microscopically, they are lined by a
single layer of cuboid, columnar, flattened (Figure 1) or pseudostratified (Figure 2), or by
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Figure 2. Serous cyst with pseudostratified epithelium. (A) Hematoxylin and eosin staining ×100. (B) Hematoxylin and
eosin staining ×400.
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Figure 3. Serous simple cyst with stratified cuboidal epithelium. Hematoxylin and eosin staining ×200.
2.2. Polycystic liver disease
Serous hepatic cysts are also linked to genetic disorders such as polycystic liver disease (PLD)
with/without autosomal dominant polycystic kidney disease (ADPKD) or Caroli disease.
Isolated PLD is associated with heterozygous mutations in PRKCSH or SEC63 genes. PLD
associated with ADPKD is linked with mutations in the PKD1 or PKD2 gene [3]. Overall
prevalence is similar for both genders, but females develop a more severe liver disease.
Pregnancy, multiparity, and use of steroids increase the risk for severe hepatic cystic disease.
Gigot and collaborators have described a classification for patients with polycystic liver disease
based on the number and size of hepatic cysts and residual normal liver parenchyma between
the cysts. This description is based on preoperative computed tomography (CT) [4]. Also, this
classification can delineate the therapeutic strategy [5].
• Type I—less than 10 large cyst (7–10 cm) with large areas of noncystic parenchyma
• Type II—diffuse involvement of liver parenchyma by medium-sized cysts (5–7 cm) with
remaining large areas of noncystic parenchyma
• Type III—massive, diffuse involvement of liver parenchyma by small- and medium-sized
cysts (less than 5 cm) and only a few areas of normal liver parenchyma between cysts [2, 4, 5]
It is of exquisite importance to differentiate hepatic cyst from hydatid hepatic cyst, hepatic
cystadenoma, and hepatic cystadenocarcinoma before proceeding with the treatment. In
certain situations, it can be very challenging to properly diagnose a hepatic cystic mass [6, 7].
There are also rare hepatic cystic lesions that must be taken into consideration [8]. In pediatric
population, the surgeon should be aware of the wide range of other types of liver cysts to
ensure appropriate treatment [9].
2.3. Localized Caroli disease or solitary dilatation of intrahepatic biliary duct
Caroli disease is an autosomal recessive inheritance linked to mutation in PKHD1 gene. It is
classified as type V choledochal cyst by the Todani classification [10]. The cystic lesions are
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depicted as irregular in shape, fusiform, or saccular (Figures 4A). On MRCP they are seen to
communicate with biliary tree (Figure 4B). On gross examination of the operative specimen,
the cystic cavity contains biliary sludge and even gallstones (Figure 5).
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Figure 4. Localized Caroli disease. (A) MRI, axial section: group of cysts in hepatic segment VIII. (B) MRCP, coronal
section: group of cysts that communicate with biliary tree.
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Figure 5. Localized Caroli disease. (A) Resected specimen with biliary cysts filled with bile sludge. (B) Histological ex‐
amination with hematoxylin nd eosin staining ×100.
2.4. Intrahepatic biliary papilloma
Biliary papilloma represents a tumorous growth of the bile duct epithelia in the bile duct lumen
and can cause a localized dilatation of the intrahepatic bile duct. If native and contrast
enhanced CT fail to observe the biliary papilloma, the bile duct dilatation may be confused
with a hepatic serous cyst. ERCP can demonstrate the communication between the cystic lesion
and the bile duct [11].
2.5. Biliary cystadenoma and cystadenocarcinoma
Biliary cystadenoma is a very rare cystic lesion of the liver that usually occurs in middle-aged
woman. The exact etiology of this insidiously progressive tumor is unknown. This cyst may
riginate from a congenitally aberrant bile duct or directl  from a primitive hepatobiliary stem
cell.
Recent Advances in Liver Diseases and Surgery252
Cystadenoma of the liver is characterized by multilocular cysts with internal septation and
epithelial lining composed of columnar to cuboidal cells capable of mucin production. They
usually contain clear mucinous fluid and rarely the fluid may be bilious, purulent, proteina‐
ceous, or hemorrhagic. Bloody fluid often signifies a malignant component [12]. The septa may
show calcifications.
Two subgroups are distinguished by presence or absence of mesenchymal (ovarian like)
stroma between an inner epithelial lining and an outer layer of collagenized connective tissue
(Figure 6).
Figure 6. Cystadenoma without mesenchymal stroma. Hematoxylin and eosin staining ×200.
The mesenchymal stroma resembles primitive mesenchyme, and cell differentiation varies
from smooth muscle or fibroblasts to adipocytes or capillaries. Cystadenoma with mesenchy‐
mal stroma occurs exclusively in women (Figure 7) possibly as a consequence of the female
milieu influence, while cystadenoma without mesenchymal stroma predominates in men [13].
Mesenchymal stroma may give rise to both cystadenocarcinoma and sarcomas. Intrahepat‐
ic  biliary  cystadenoma cannot  be  clearly  differentiated  from cystadenocarcinoma before
operation.  Some  authors  consider  the  diagnostic  value  of  the  analysis  of  serum  and
aspirated cyst fluid for tumor markers. However, elevated carbohydrate antigen CA 19-9
and  carcinoembryonic  antigen  CEA  has  been  associated  both  with  cystadenoma  and
cystadenocarcinoma  [14].  Only  histopathologic  exam  can  certainly  differentiate  it  from
malignant degeneration. Being considered a premalignant lesion, surgical excision seems
to be a wise decision in patients with intrahepatic biliary cystadenoma. If not completely
resected,  the  recurrence  in  biliary  cystadenoma  is  greater  than  90%  [12].  Moreover,  if
malignancy  is  not  recognized,  a  simple  fenestration  may  prove  catastrophic  to  patient.
Patients  with  cystadenocarcinoma  with  mesenchymal  stroma  have  a  good  prognosis,
whereas cystadenocarcinoma in men, which is not associated with mesenchymal stroma,
has a worse prognosis, even after complete excision [15].
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2.6. Bile duct hamartoma
Bile duct hamartomas, also called von Meyenburg complexes, originate from embryonic bile
ducts that fail to involute. Generally, they are encountered as an incidental finding at imaging,
laparotomy, or autopsy. Macroscopically, they are cyst-like, grayish-white nodular lesions of
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Figure 7. Cystadenoma with mesenchymal stroma. (A) Hematoxylin and eosin staining ×200. (B) Hematoxylin and eo‐
sin staining ×400. (C) Immunohistochemical staining CK7 ×200. Cyst epithelium is positive for CK7. (D) Immunohisto‐
chemical staining CK8-18 ×200. Cyst epithelium is positive for CK8-18. (E) Immunohistochemical staining ER ×400.
Mesenchymal stroma contains cells (brown cells) that are positively stained for estrogen receptors. (F) Immunohisto‐
chemical staining PgR ×400. Mesenchymal stroma contains cells (brown cells) that are positively stained for progester‐
one receptors.
Recent Advances in Liver Diseases and Surgery254
associated with Caroli’s disease, PLD and congenital fibrosis. In case of intraoperative
discovery, they may be misdiagnosed as liver metastases.
2.7. Ciliated hepatic foregut cyst
Ciliated hepatic foregut cysts are rare foregut developmental malformation usually solitary
and unilocular. Generally, these are situated in the central segments of the liver (Figure 8).
These cysts are characterized by the typical microscopic finding of four layers (the inner
ciliated, pseudostratified, columnar epithelium; subepithelial connective tissue; smooth
muscle layer; and an outer fibrous layer at microscopic examination). Squamous metaplasia
may be present with potential transformation into squamous cell carcinoma. Malignant
transformation to squamous cell carcinoma with aggressive behavior has been reported in 3%
of adult cases [4, 16].
Figure 8. CT series showing a hepatic cyst situated in segment VIII, with an extension that is traced on the hepatic
surface, raising the question of ciliated hepatic foregut cyst in a 14-year-old girl. The patient was submitted to open
surgery due to the close proximity with the inferior vena cava and hepatic vein.
2.8. Intrahepatic pancreatic pseudocyst
Hepatic pseudocyst secondary to acute pancreatitis is extremely rare and is generally situated
in the left lobe. A high level of amylase in the aspirated fluid confirms the diagnosis. Asymp‐
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tomatic intrahepatic pseudocyst can be treated conservatively, and symptomatic intrahepatic
pseudocyst can be managed either percutaneously or surgically [17].
2.9. Posttraumatic hepatic cyst
Only those symptomatic or of uncertain nature need treatment.
2.10. Biloma
Biloma appears as a cystic mass. It is caused by spontaneous, traumatic, or iatrogenic rupture
of the biliary system.
2.11. Peribiliary cysts
Peribiliary cysts are mostly encountered in cirrhotic patients with portal hypertension or after
liver transplantation. The cysts are located along the portal pedicles. Usually they are small
and asymptomatic.
2.12. Liver hematoma
Liver hematomas are cystic lesions that develop after trauma, liver biopsy, or surgery.
2.13. Hepatic epidermoid cyst
Liver epidermoid cysts are extremely rare. These malformations have been diagnosed in
pediatric patients, with the youngest one being 5 months years old. The importance of resection
of such cystic lesions in pediatric population resides in the need of elimination of a lesion lined
by squamous epithelium with possible squamous metaplasia that can potentially undergo
malignant transformation, resulting in squamous cell carcinoma.
2.14. Postcholecystectomy hepatic cystic mass
The term of gossypiboma derived from the Latin term gossypium is used to define a forgotten
surgical material in the body after surgery. Sometimes gossypiboma has a cyst-like appearance
on imaging tests.
2.15. Hepatic endometriosis
So far only 22 cases of hepatic endometrioma have been reported in the literature [18]. Hepatic
endometriosis should be considered in women of any age presenting with a hepatic cystic
mass, with or without previous endometriosis history. Frozen sections of intraoperative
transhepatic biopsy are necessary to avoid radical hepatectomy in order to decrease postop‐
erative morbidity and mortality. However, the diagnosis is confirmed through histological
immunostaining. Complete pericystectomy is necessary to avoid recurrence.
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2.16. Hepatic vascular tumors
There are hepatic vascular tumors with predominantly solid appearance at gross examination
but with cyst-like appearance on imaging examinations due to the high water content.
Histopathological diagnosis must differentiate between lymphangioma, hemangioma,
hemangiopericytoma, or undifferentiated embryonal sarcoma (Figure 9).
2.17. Liver metastases
Liver metastases from ovarian, pancreatic, colon, renal, or neuroendocrine cancer may have
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Figure 9. Hepatomegaly caused by multiple bilateral liver vascular tumors with cystic features on CT and operative
specimen. (A) CT, axial view. (B) CT, coronal view. (C) CT with i.v. contrast, axial view, after left lateral sectionectomy.
(D) CT without contrast, axial view after left lateral secti nectomy. (E) Resected specimen after left lateral sectionecto‐
my with hemorrhagic cystic feature on section. (F) Intraoperative aspect of the hepatic vascular tumor. (G) Resected
specimen after atypical hep tectomies for the tumors located in the right lobe, with morrhagic cystic feature on sec‐
tion.




Generally, patients with nonparasitic hepatic cysts less than 3 cm are asymptomatic [2]. Cysts
are classified as “large” when they are greater than 4 cm in the longest diameter. If the diagnosis
of hepatic serous cyst is clear, there is no need of treatment, unless it becomes symptomatic,
has a diameter more than 5 cm, or if the cyst grows rapidly within a short period of time [19].
Around 15% of patients with liver cysts develop symptoms at some stage in life. When the
patients start complaining, the most common symptom is pain in the right upper quadrant.
Other encountered symptoms are nausea, vomiting, abdominal meteorism, shoulder or
lumbar pain, dyspnea, and/or postprandial fullness. Hepatic cysts become symptomatic when
they are large, fast growing, multiple, or complicated.
3.1. Complications
Complications occur in approximately 10% of patients [20]. Obstructive jaundice, portal
hypertension, intracystic hemorrhage, infection, intraperitoneal and/or intrahepatic rupture,
torsion, and inflammation represent complications of nonparasitic hepatic cysts [21–24]. The
compression exerted by a large hepatic cyst on the adjacent structures can manifest as cardiac
arrhythmia or inferior vena cava thrombosis [25, 26]. The vicinity with the cholecyst can cause
its functional disturbance with consecutive gallstones.
Hemorrhage into a simple liver cyst is rather uncommon but poses issues regarding differential
diagnosis. The differential diagnosis between intracystic hemorrhage, cystadenoma, and
cystadenocarcinoma is difficult with the imaging studies currently available. One consequence
is to assume a simple cyst with intracystic hemorrhage as being neoplastic lesion and perform
an unnecessary hepatectomy. The other consequence is to assume a neoplastic lesion as being
benign and perform laparoscopic fenestration with subsequent peritoneal dissemination of
malignant cells.
There are situations when an intracystic hemorrhage occurs unrecognized. Even if no acute
symptoms supervene, the hemorrhage causes a rapid enlargement of the cyst, raising suspicion
of malignant degeneration.
Infection of hepatic cyst can occur through common bile duct or blood stream. The most
common encountered microorganisms are Escherichia coli and Klebsiella pneumoniae. Proteus,
Bacteroides, and Clostridium are also incriminated in infection of hepatic cysts. The most likely
source of infection for simple liver cysts is the gastrointestinal tract. Diverticulitis of the
sigmoid colon and gut manipulation during abdominal operations have been found to be the
cause of infectious complications of hepatic cysts [27]. The patients with diabetes mellitus,
undergoing chronic hemodialysis or immunosuppressive therapy (e.g., after kidney transplant
in patient with polycystic liver and kidney disease), are prone to develop such infections.
The patient with infected liver cyst presents with acute onset of right upper quadrant abdomi‐
nal pain, diarrhea, and/or fever. There are situations when pain is absent, and the only
symptoms are fever and malaise that render a complete workup to rule out other causes.
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The rupture of serous hepatic cyst is a rare complication that needs emergency intervention.
The cyst rupture is generally secondary to trauma, but a spontaneous one is also possible. The
cyst fluid can enter the pleural or peritoneal cavity, causing pain in right upper quadrant or
even diffuse abdominal pain due to peritoneal irritation.
Granuloma degeneration is a rare complication of the hepatic cysts (Figure 10). In severe form,
it can resemble malignant invasion into surrounding tissues. The differential diagnosis is
difficult to make even intraoperatively. Extensive excision of involved tissues is sometimes
necessary [28]. Eventually histology delineates the diagnosis.
Figure 10. Serous cyst with granulomatous transformation, hyaline collagen fibrosis and focal, nonspecific chronic in‐
flammation. Hematoxylin and eosin staining ×100.
4. Diagnosis
Percutaneous abdominal ultrasonography (US) is the best imaging modality for diagnosis of
serous hepatic cysts. US is generally the first choice diagnostic procedure because it is sensitive,
specific, noninvasive, and ready available. The typical appearance of simple cyst on US is as
follows: round or oval anechoic mass, well circumscribed, with thin and smooth borders or
indiscernible walls, strong posterior echo enhancement, without mural vegetations, calcifica‐
tions, or septations (Table 1).
Although US can offer reliable data regarding relations of the hepatic cysts to the vascular and
biliary tree, the standard diagnostic protocol in our clinic includes CT with i.v. contrast
substance. MRI is also useful to establish a correct diagnosis (Algorithm 1) [29].
Intraoperative use of an ultrasound probe, where the abdominal wall thickness is not an issue,
allows the placement of a higher MHz ultrasound transducer directly on the liver surface.
Therefore, intraoperative ultrasound images are much sharper and well defined than those
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obtained through a transabdominal approach. Intraoperative US not only confirms the
diagnosis but also adds important information to define the relation between the cysts and the
surrounding structures (portal and hepatic veins, inferior vena cava, bile ducts), especially in
deeply located cysts. Intraoperative US is also used to guide the surgeon for cyst approach in
case no capsular expression is found. For laparoscopy, specially designed ultrasound probe
and software are necessary.
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Table 1. Ultrasonographic features for the diagnosis of monocystic diseases of the liver
CT and MRI can resolve the diagnosis of the doubtful cases and provide more information on
the location of the cyst and relations with the great vessels and biliary tree. Thus, CT and/or
MRI are mandatory for an appropriate treatment planning. US, CT, and MRI are complemen‐
tary in evaluation of hepatic cysts. Based on imagistic examinations, parasitic cysts, neoplastic
degeneration, and complications must be ruled out before pursuing any therapy decision.
On CT scan, simple hepatic cysts are well-defined, space occupying, round or oval-shaped,
thin-walled, homogenous masses, with a density close to water (0–5 Hounsfield) and modest
enhancement after contrast injection.
The presence of septa is not a common feature of the simple cyst, but multiple contiguous cysts
can simulate it. For countries where hydatid disease is endemic, the differential diagnosis must
include it because it is essential for therapeutic decision making.
The injection of intravenous contrast allows the manifestation of a possible communication
between the cyst and the biliary tree on CT and MRI [29]. The communication of the hepatic
cyst with the bile ducts can also be visualized using cystography, intraoperative cholangiog‐
raphy, and ERCP.
The mural calcifications are nonspecific but are usually present in echinococcal cysts and
malignant lesions.
MRI provides valuable information concerning the nature of the cyst content and helps
differentiating between blood and mucin [12]. MRI can identify a hypointense pseudocapsule
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characteristic of the echinococcal cyst. MRI, especially associated with MRCP, is helpful for
the diagnosis of biliary cysts, localized Caroli disease (Figure 4), intrahepatic biliary cystade‐
noma, and cystadenocarcinoma.
A liver cyst with intracystic hemorrhage appears as a heterogeneous echogenic cyst on US. For
improved US imaging, an ultrasound contrast substance (e.g., Levovist, Bayer Australia
Limited; SonoVue, Bracco International B.V.) can be used. The procedure is known as contrast-
enhanced ultrasound (CEUS) and uses a microbubble agent that produces multiple small
(approximately 3 μm) stabilized air bubbles when suspended in water. After intravenous
injection of Levovist, Doppler enhancement of the blood pool is observed for 2–5 min, followed
by a late hepatosplenic phase that lasts for more than 30 min. If no enhancement of the
intracystic structures but an enhanced smooth cyst wall is observed on Levovist US, then an
intracystic clot is suspected. On plain CT, the hemorrhagic cyst appears heterogeneous low-
density (Figure 11). On MRI, T1-weighted images reveal the clot as low intensity and the fluid
as high intensity, whereas T2-weighted images show the clot as low intensity and the fluid as
high intensity [30].
Figure 11. CT, axial view: multiple hepatic cysts, the largest cyst, located in segment VI–VII is ruptured in hepatic pa‐
renchyma; intracystic hematoma and extensive subcapsular hematoma are visible on the right hepatic lobe. (A, C) Na‐
tive examination; (B,D) Examination with i.v. contrast administration.
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On US, the differential diagnosis between intracystic hemorrhage and neoplastic degeneration
may be challenging when intracystic parietal protrusions are identified (Figure 12). If no
Doppler signal exists, these protrusions may be interpreted as sedimentations of hematin on
the cyst wall. On macroscopic examination during operation, these protrusions have the
equivalent of the blackish-brown deposits that stain the cyst wall. If Doppler signal is certified
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Figure 12. Transabdominal US for a cystic mass in the liver: the mass is anechoic, homogenous, with thin border, with‐
out calcifications, but with small hyperechoic parietal protrusions that do not change with patient’s position. On Dop‐
ple  examination, these protrusions are vascular and on CT are not v sible. The in raoperative and histological
diagnosis was serous hepatic cyst with hemorrhagic content. Cystadenocarcinoma had to be ruled out. Patient was
submitted to open surgery.
Gallium scintigraphic study can be used to search for the site of infection in a patient with a
previous diagnosis of simple hepatic cyst [27]. 18-F-fluorodeoxyglucose is helpful for the
detection of cyst infection using positron emission tomography in patients with multiple liver
and renal cysts [31]. In a patient diagnosed with hepatic cyst, any febrile status should raise
the question of its possible infectious complication.
In case of cyst rupture, on imaging scans, irregularities of the partially evacuated cyst wall,
heterogeneous content, fluid under the liver capsule, or free liquid in the peritoneal or pleural
cavity are depicted.
Nonparasitic hepatic cysts may coexist with other hepatic lesions, bringing out the issue of
correlation the lesion with the patient’s symptoms and also of adopting the right management
decision.
Nonparasitic cysts may coexist with parasitic ones (Figure 13). Even if the size of nonparasitic
cyst does not justify its fenestration, it is recommended to solve both types of cysts in the same
operation in order to avoid future misdiagnosis between the nonparasitic and parasitic cyst.
Nonparasitic hepatic cysts may coexist with other benign or malignant liver tumors. When a
benign tumor lesion (e.g., hepatic hemangioma) is diagnosed besides hepatic cyst, there is an
issue regarding which lesion should be treated to elevate the pain in the right upper quadrant
(Figure 14).
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Figure 14. CT showing coexistence of two hepatic lesions: central simple hepatic cyst, in close proximity with gallblad‐
der, and hepatic hemangioma in segment VI. (A) Axial view, native; (B) axial view, after i.v. contrast, arterial phase;
(C) sagittal view, after i.v. contrast, arterial phase. Patient was submitted to laparoscopic fenestration of the hepatic
cyst. The operation was successful in abolishing the right quadrant pain.
Nonparasitic cysts can also coexist with peripheral cholangiocarcinoma. The association was
found in patients with PLD after kidney transplantation. The presence of liver metastasis from
colorectal cancer was also found in patients with PLD (Figure 15).
Figure 15. CT, axial view, with (A) and without (B) i.v. contrast showing coexistence of a bulk solid liver metastasis
from colonic cancer in a patient with previously known PLD.
Figure 13. CT, axial view: voluminous hydatid cyst in the right hepatic lobe and small cyst mass in segment II-III. (A)
Native; (B) after administration of i.v. contrast.
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Serological tests for Echinococcus are electrosyneresis, hemagglutination, and ELISA (enzyme-
linked immunosorbent assay) (the latter two being quantitative) [32]. The specific serology for
Echinococcus has a sensitivity of 80% in the diagnostic process of parasitic cysts.
Serum tumor markers (e.g., CA 19-9 and CEA) must be checked to rule out neoplasia.
Right upper pain requires workup to exclude other associated pathology that may be the only
or in addition responsible for causing the symptoms. Thus the surgeon should rule out
cholelithiasis, gastroesophageal reflux disease, peptic ulcer disease, acute gastritis, or color‐
ectal cancer. Upper and lower gastrointestinal endoscopy can reveal such pathologies and help
avoiding misdiagnosis and mistreatment based solely on the pain supposedly caused by the
hepatic cyst.
5. Treatment
Asymptomatic single liver cysts do not require treatment or surveillance. Symptomatic and
complicated hepatic cysts require therapeutic intervention (Algorithm 2). It is considered that
surgery is necessary for cyst of more than 5 cm in diameter. The primary indication for surgery
is troublesome pain.
5.1. Percutaneous treatment
Percutaneous aspiration under ultrasound guidance of the cyst fluid is a mini-invasive
procedure with a high recurrence rate if it is not associated with injection of a sclerosing agent
in the remnant cavity.
Percutaneous treatment is performed on an inpatient basis under local anesthesia with
lidocaine or sedation. For cyst puncture, an 18-gauge aspiration needle can be used. The
puncture line must be chosen through normal hepatic parenchyma to avoid fluid leakage into
peritoneal cavity. To prevent intracystic bleeding during evacuation caused by the sharp
contact of the needle with the cyst wall, a 6- to 7-F catheter can be used instead. After complete
evacuation of the cyst, the fluid is sent to cytological and bacteriological examination. Even in
the absence of obvious signs of communication of the cyst with the biliary tree, this possibility
must also be ruled out before injecting the sclerosant. Otherwise, an irreversible sclerosing
cholangitis may supervene. There are available some imagistic methods to check the commu‐
nication between liver cyst and biliary ducts. The most feasible and reliable method is the
injection of a diluted US contrast agent (e.g., 2–4 drops of SonoVue, Bracco International B.V.
in 40–200 ml 0.9% saline) in the evacuated cyst. The volume of contrast agent injected is the
same or lower than the aspirated one [33]. Other alternative methods in ruling out cyst–biliary
tree communication are cystography, ERCP, and bile duct scintigraphy [23].
Only after the absence of biliary communication is certified, the instillation of the sclerosant is
allowed. One has to choose from a list of sclerosing agents that include ethanol [34–36],
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minocycline hydrochloride [37], tetracycline chloride [38], hypertonic saline solution [39],
polidocanol [40], and ethanolamine oleate [41].
Ethanol has remained the most used sclerosing agent. It destroys the cell lining of the cystic
cavity and discontinues the cystic fluid secretion. Different concentrations of ethanol (95–99%)
and different volumes (10–50% of the cystic volume) have been reported. The exposure time
varies from 10 min to 4 h. In order to minimize ethanol side effects, time exposure to ethanol
should be less than 60 min. When using ethanol instillation, the cyst must be completely
evacuated, a condition that is not necessary when using other sclerosing agents. After complete
cyst evacuation, its walls collapse hampering the thorough distribution of sclerosant, with the
risk of its subsequent lobulation. The other sclerosants are active in small concentration and
do not need complete evacuation of the cystic fluid. When the cyst is only partially evacuated,
the misplacement of needle tip is also avoided. The residual fluid is progressively resorbed
through microscopic communication between the cyst and the surrounding liver parenchyma.
Polidocanol needs only one application. Its application is painless and hence no intracystic
anesthesia or sedation is required [33].
The percutaneous treatment can be repeated when necessary. Percutaneous drainage must be
done under antibiotic prophylaxis. The recommended antimicrobial is ciprofloxacin because
cephalosporins (e.g., cefazolin) were not found totally successful in preventing cyst infection
after drainage [42]. Even if infection of the remnant cavity occurs, it can be remitted by oral
Ciprofloxacin (500 mg twice daily) associated or not with clindamycin (300 mg three times
daily) [42]. Oral ciprofloxacin is also indicated as the first line treatment in infected cysts [43].
5.2. Radiofrequency ablation
Radiofrequency ablation (RFA) for the treatment of hepatic cysts with the largest diameter up
to 10 cm was reported to be efficient, safe, and free from complications [44].
5.3. Surgical treatment
High success rates in the treatment of hepatic cysts were reported being associated with
laparoscopic or open deroofing [24].
5.3.1. Laparoscopic approach
Laparoscopic fenestration was first reported by Z’graggen in 1991 [45]. Being associated with
low recurrence rate, reduced morbidity, and short hospital stay, laparoscopic fenestration
tends to become the standard treatment for the simple hepatic cysts.
The indications for laparoscopic approach are determined not by the size but the location of
the cysts, being limited to those located in the segments II, III, IV, V, and VI (Figure 16) [29].
However, some authors advocate that the use of a flexible laparoscope facilitates the laparo‐
scopic approach of lesions located in the postero-superior segments of the liver (segments I,
VII, and VIII) [46]. Hepatic cysts that cannot be entirely explored laparoscopy are not candi‐
dates for laparoscopic approach.
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Figure 16. CT showing serous hepatic cyst in segment VI–VII. (A) Axial view, (B) coronal view, and (C) sagittal view.
Laparoscopic approach is not indicated for such localization of the hepatic cyst.
Laparoscopy is not suitable for fenestration in case of close proximity of the cyst wall to the
hepatic veins and inferior vena cava (Figure 17) [47].
Figure 17. CT, axial view, with contrast (A) and without contrast (B): large simple hepatic cyst in contact with the infe‐
rior vena cava and hepatic veins and other two small cysts in proximity. Patient was submitted to open surgery.
Previous laparotomies or laparoscopies are not considered contraindications to the laparo‐
scopic approach.
A 30° laparoscope is used. A medium CO2 insufflation and an intra-abdominal pressure less
than 12 mm Hg should be used to avoid gas embolism. Liver veins are little prone to col‐
lapse in the supine position. The effect of venous gas embolism depends on the rate of CO2
infusion and its volume. For adults, the potentially lethal volume is estimated at 200–300 ml
or 3–5 ml/kg [48]. Surgeons must routinely purge laparoscopic tubing systems with CO2 gas.
If the system is not adequately purged with CO2 gas before, substantial amounts of air (con‐
taining 79% of the insoluble N2) may be insufflated into the peritoneal cavity from the tub‐
ing and may cause air embolism [48].Generally, the patient lies in the supine position with/
without abducted legs or lithotomy position on the operating table. A left side-lying posi‐
tion of the patient can help approaching liver cysts located in the segments V-VI.
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The operative procedure in the standard operation of fenestration is performed using three or
four ports. One 10-mm trocar is inserted into the abdominal cavity through the umbilicus as
an observation port. The main operating hole is located under the xiphoid and is made to
accommodate a 10- or 12-mm trocar. Another hole is placed in the right upper quadrant of the
abdomen at the medioclavicular line for insertion of a 5-mm trocar. An additional port can be
placed for exposure, depending on the cyst localization.
On video inspection, the liver mass appears exteriorized on the hepatic surface with a
translucent wall. If the serous hepatic cyst has no complication, there are no tight adhesions
to the surrounding tissues. Instead, if the cyst is complicated by inflammation, infection, or
hemorrhage, the surface of the corticalized cyst may develop tight adhesions to the surround‐
ing organs and the cyst wall appears thick and thus indistinguishable from other hepatic cysts





On video  inspection,  the  liver mass appears exteriorized on  the hepatic  surface with a  translucent wall.  If  the  serous 
hepatic  cyst  has  no  complication,  there  are  no  tight  adhesions  to  the  surrounding  tissues.  Instead,  if  the  cyst  is 
complicated by inflammation, infection, or hemorrhage, the surface of the corticalized cyst may develop tight adhesions 





cyst with  adhesions  to  the diaphragm  and with  thick wall  that make  it undistinguishable  from 
hydatid  cyst.  (B)  Intraoperative  aspect  of  the  aspirated  liquid. The  brownish  color  is  likely  the 
result of an unrecognized intracystic hemorrhage.
 
After  cyst  evacuation,  a  large  access  to  the  cavity of  the  cyst  should be obtained. The walls of  the  cyst  are  carefully 
inspected  to  identify  possible  indentation,  vegetation,  or  thickness. Any  suspicious  lesion  of  the  cyst wall must  be 
biopsied and  send  to  frozen examination  to  rule out malignancy.  If neoplastic  changes are  found,  the  laparoscopy  is 
converted  to  open  operation,  and  liver  resection  is  performed.  If mural  nodules,  intracystic  septum,  or  honeycomb 
appearance  is  visualized,  but  there  is  no  microscopic  evidence  of  cystadenoma  or  cystadenocarcinoma  on  frozen 
sections, hepatectomy can be performed laparoscopically to clear all the affected segments.                                                                                
Any  suspected  communication  with  the  bile  duct  should  be  carefully  investigated  intraoperatively.  Some  authors 
consider the closure of the open bile duct under laparotomy to be a more rational choice [49]. Other authors advocate for 
laparoscopic closure of the communication with the bile duct [50]. 
Recurrence  is  low  if wide cyst wall resection  is accomplished. Fenestration can be carried out by electrocautery hook, 
bipolar  scissors,  high  frequency  bipolar  electrocoagulation  LigaSureTM  (Valleylab,  Tyco  International  Healthcare, 
Boulder, CO), Ethicon Ultracision Harmonic Scalpel LCS‐5  (Ethicon, Cincinnati, Ohio), or cutting stapler. Argon beam 
coagulation may complete hemostasis. The cystic dome is resected up to 3–5 mm from the hepatic parenchyma to avoid 
hemorrhage  and  bile  leakage  from  the  cut  edge  of  the  liver  parenchyma.  The  resected  cyst  is  sent  for  permanent 
histopathologic evaluation. If the cyst is not well corticalized on the liver capsule and the standard unroofing of the cyst 
is considered of inadequate size that can predispose to recurrence, then the cyst wall should be excised including a 3‐ to 
4‐mm  rim of hepatic parenchyma.  If  the bile  is spotted along  the cystic edge, a hemostatic clip or a  tie suture can be 
applied [46].  
In  case  of  aspiration  of  a  straw‐colored  liquid  and  in  the  absence  of  bile  staining  of  the  cystic wall,  intraoperative 
cholangiography is not indicated. However, in case of bile contamination of the cyst or compression of the biliary tree, 
intraoperative  cholangiography  is  required  to  evaluate  the  biliary  tree  [51].  Intraoperatively  missed  biliary 
communication could lead to prolonged biliary fistula and even biliary peritonitis. 
Sclerosant  or  alcohol  application  on  the  remnant wall  of  the  cyst  is  recommended  to  prevent  possible  further  fluid 
secretion  by  cyst  epithelium  and,  hence,  hepatic  cyst  recurrence.  The  great  omentum  should  be  packed  into  larger 
cavities to decrease dead space and prevent fluid collection. An omental flap transposition is recognized as an important 
                              
                                     
                                         
                                       
                                 
                                     
                                         
                         
Figure 18. Serous cyst in the segments IV, V, and VIII. (A) Intraoperative aspect of the complicated hepatic cyst with
adhesions to the diaphragm and with thick wall that make it undistinguishable from hydatid cyst. (B) Intraoperative
aspect of the aspirated liquid. The browni h olor is likely the result of an unrecognized intracystic hemorrhage.
After cyst evacuation, a large ac ess to the cavity of the cyst should be obtained. The walls of
the cyst are carefully inspected to identify possible indentation, vegetation, r thickness. Any
su picious lesio  of the cyst wall must be biopsied and sent to frozen examinati n to rul  out
malig ancy. If neoplastic changes are found, the laparoscopy is converted to open operati n,
and l ver resection is performed. If mural nodules, intracystic s ptum,  honeycomb appear‐
anc  are visualized, but there is no mi roscopic evidence o  ystadenoma or cystadenocarci‐
noma on frozen sections, pat ctomy can be performed laparoscopically to clear all the
affected segments.
Any suspected communication with the bile duct should be carefully investigated intraoper‐
atively. Some authors consider the closure of the open bile duct under laparotomy to be a more
rational choice [49]. Other authors advocate for laparoscopic closure of the communication
with the bile duct [50].
Recurrence is low if wide cyst wall resection is accomplished. Fenestration can be carried out
by electrocautery hook, bipolar scissors, high frequency bipolar electrocoagulation Liga‐
SureTM (Valleylab, Tyco International Healthcare, Boulder, CO), Ethicon Ultracision Harmonic
Scalpel LCS-5 (Ethicon, Cincinnati, Ohio), or cutting stapler. Argon beam coagulation may
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complete hemostasis. The cystic dome is resected up to 3–5 mm from the hepatic parenchyma
to avoid hemorrhage and bile leakage from the cut edge of the liver parenchyma. The resected
cyst is sent for frozen section and permanent histopathologic evaluation. If the cyst is not well
corticalized on the liver capsule and the standard unroofing of the cyst is considered of
inadequate size that can predispose to recurrence, then the cyst wall should be excised
including a 3- to 4-mm rim of hepatic parenchyma. If the bile is spotted along the cystic edge,
a hemostatic clip or a tie suture can be applied [46].
In case of aspiration of a straw-colored liquid and in the absence of bile staining of the cystic
wall, intraoperative cholangiography is not indicated. However, in case of bile contamination
of the cyst or compression of the biliary tree, intraoperative cholangiography is required to
evaluate the biliary tree [51]. Intraoperatively missed biliary communication could lead to
prolonged biliary fistula and even biliary peritonitis.
Sclerosant or alcohol application on the remnant wall of the cyst is recommended to prevent
possible further fluid secretion by cyst epithelium and, hence, hepatic cyst recurrence. The
great omentum should be packed into larger cavities to decrease dead space and prevent fluid
collection. An omental flap transposition is recognized as an important aid in reducing the risk
of cyst recurrence, but it is contraindicated in infected cysts.
The drainage of the remnant cavity must meet the declivity principle, especially for those cysts
situated in the upper liver segments. The main reason for reconstitution of the cyst after
operation is the coverage of the remnant cavity by the diaphragm. To establish a dry residual
cavity after fenestration of liver cysts located in the segments VII and VIII, the vacuum effect
of the respiratory movements of the diaphragm should be counteracted by an efficient external
drainage. The drainage tube should be left in place until complete cessation of the secretion
certified by ultrasound evaluation. The use of pigtail catheters for drainage is preferred to the
usual drainage tubes for upper sited liver cysts. The realization of an efficient external drainage
might be accomplished by transparenchymatous placement of the tube.
The atypical hepatic resections for large and/or multiple hepatic cysts that occupy more
segments are laparoscopically feasible if performed by surgeons with advanced training in
this technique. Most of these atypical hepatectomies involve the left lobe (Figure 19). Generally,
the cut surface of the liver remains covered by the cyst wall.
5.3.2. Single-incision laparoscopy
Single-incision laparoscopic surgery can reach the effect of “no scar” and can be safely and
effectively carried out in these patients. The operation is performed using a dedicated port
such SILSTM Port (Covidien, MA, USA), GelPort® Laparoscopic System (Applied Medical,
CA, USA), QuadPort+ (Olympus, PA, USA), or X-cone (Karl Storz, Germany). However, three
trocars can also be used by their insertion into abdominal cavity through one 2.5-cm incision
designed along the ventral midline on the upper edge of the umbilicus. The incision is sufficient
to accommodate one 10-mm trocar and two 5-mm trocars [19]. The abdominal drainage tube
can be appropriately placed through the same incision at the end of cyst fenestration. If the
telescope cannot directly observe the liver cyst, the patient is not suited for single-incision
laparoscopic surgery.
Diagnostic and Therapeutic Challenges in Nonparasitic Liver Cysts
http://dx.doi.org/10.5772/61057
269
Minilaparoscopic-assisted transvaginal approach is also mentioned [52].
5.3.3. Robotic approach
Robotic surgery is another possible approach, and it has been used in our clinic for nonparasitic
hepatic cyst fenestration. The use of the Da Vinci robotic surgical system has certain technical
advantages over the standard laparoscopic technique in case of the posterior location of the
liver cysts [53]. However, conversion to laparoscopic or open surgery in case of difficulty is
laborious and time consuming and could be life-threatening in a dire emergency.
5.3.4. Classic approach
The communication between cystic cavity and bile duct encountered during operation can be
managed in different ways. The suture of the biliary communication is enough, but the means
of doing that depend on different surgeons. Cystojejunostomy is mentioned by some authors
[54], but it became history in our clinic. Biliary-enteric anastomosis is necessary if there is a
concern of postoperative leak or intrahepatic biliary obstruction after suture control [55].
If cystadenoma is suspected, due to its malignant potential, the recommended therapy is
laparoscopic or open cyst enucleation or liver resection. But if any suspicion of cystadenocar‐
cinoma exists or especially if malignancy is proved by cytology of aspirated cyst fluid or frozen
sections, the surgical decision should be open liver resection with tumor-free margins.
Enucleation is generally feasible due to the existence of a well-defined plane between the cyst
wall and the normal liver parenchyma that is generally avascular (Figure 20). For cysts
centrally situated, with an increased risk of intraoperative hemorrhage, Pringle maneuver
Figure 19. Patient with PLD and ADPKD operated by laparoscopic approach for hepatic cysts. CT in axial view shows
small serous cysts grouped in segments II and III (A) and a large serous cyst in segment IV (B). Laparoscopic interven‐
tion was successfully performed.
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brings clear benefits. If there is a direct contact of the cyst wall with the portal pedicle, hepatic
vein, or inferior vena cava, that portion of the wall can be abandoned if no malignancy is
identified on frozen sections (Figure 21). However, there still remains the risk of abandoning
malignant areas or malignant degeneration of the remnant cyst wall over time. For this reason,
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it is recommended to destroy the epithelium lining of the remnant cyst wall by electrofulgu‐
ration or argon beam coagulation.
In case of  malignant cytology and/or histopathology,  the only potentially curative treat‐
ment is complete removal of the hepatic cyst,  usually by a major liver resection with 1-
cm free margin [15].
The elective treatment for the infected hepatic cysts is antibiotherapy combined with percu‐
taneous drainage. It is thought that infection itself kills the inner epithelium, so the regular use
of sclerosant injection into the cyst is not generally adopted by some authors. A shortening of
time for sclerosant instillation is suggested by others [56]. In case of failure of the mentioned
treatment, there is a need for surgery.
When intracystic or intraparenchymatous hemorrhage is certain, the active bleeding with
negative hemodynamic impact imposes emergency operation. Otherwise, the percutaneous
treatment can be the first option.
In dealing with cyst rupture, there is no standard therapy. In the presence of peritoneal
irritation or internal hemorrhage signs, emergency operation is the rule. In the absence of such
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Figure 20. Recurrent cyst in segments IV–V with close proximity to the right portal pedicle (A) and gallbladder (B) on
CT, coronal views. Intraoperative aspect of a thick cyst wall (C) and of hepatic parenchyma after cyst enucleation (D).
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Figure 21. Intraoperative feature of the abandoned wall of a huge serous cyst that occupied segments IV and VIII and
contained a chocolate-like fluid. The hemostasis on the hepatic rim was achieved by continuous suture.
5.3.5. Treatment of PLD
The appropriate treatment of PLD is based on Gigot’s classification on CT findings. Most
current therapies are invasive. However, the conservative management with lanreotide, a
long-acting somatostatin analogue, is promising, being associated with a reduction of liver
volume in PLD [58, 59]. Sclerotherapy is considered ineffective in the management of PLD.
Laparoscopic fenestration is feasible only for PLD type I in Gigot’s classification (Figure 22).
For type II, open fenestration is indicated. For type III, only liver resection or liver transplan‐
tation is permitted in symptomatic patients. If liver transplantation is anticipated, fenestration
or resection should be avoided to decrease postoperative morbidity and mortality.
5.3.6. Liver transplantation for PLD
Most of the patients with PLD have combined liver and kidney cystic disease. There are
questions regarding whether kidney and liver transplantation must be performed and whether
these transplants should be performed simultaneously or consecutively. The patients with
advanced renal failure (dialysis or predialysis stage) need combined liver and kidney replace‐
ment. However, those patients who have normal renal function do not need a combined
transplantation. It was reported that maximum 33% of the patients who first received a liver
transplant alone needed a kidney transplant later [60]. In many patients, the renal function
improves after orthotopic liver transplantation (OLT), possibly due to the release of compart‐
ment syndrome. Massive hepatomegaly causes an abdominal compartment syndrome that
negatively affects renal function which can be reversed after OLT. Other authors argue that a
combined liver and kidney transplantation should be performed even in patients with limited
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renal dysfunction or even normal renal function. This strategy is justified by the progression
of cystic renal disease after OLT and the immune advantage in transplanting both organs
harvested from the same donor, rather than having to perform a third-party kidney trans‐
plantation later [61].
OLT is a rare procedure for PLD. It represents approximately 1% of all indications [62]. Total
hepatectomy followed by OLT offers the chance of definitive treatment. The indication of OLT
may be too drastic considering the absence of immediately life-threatening liver failure, the
potential hazards associated with OLT procedure and postoperative immunosuppression, and
the organ shortage. Indications for OLT in PLD are massive hepatomegaly, compartment
syndrome, and clinically advanced malnutrition that produce severe physical and social
handicap. Generally, these patients have preserved liver function and normal model for end
stage liver disease (MELD) score if they do not have renal involvement [63].
Two drawbacks to OLT for patients with PLD are the susceptibility to infection caused by
severe malnutrition and overimmunosuppression, and further degradation of renal function
caused by immunosuppression. Therefore, the maintenance of immunosuppression in such
patients must be lower than usual and the steroids should be discontinued after 3 months. It
is also important not to delay OLT in these patients; otherwise, complications such portal vein
thrombosis, portal hypertension, Budd–Chiari syndrome, peripheral cholangiocarcinoma, and
liver failure may result in poorer tolerance of the patient to procedure, increased graft loss,





Figure  22.  CT  for  a  female  patient  with  PLD  submitted  to  laparoscopic 
fenestration of the largest cysts situated in hepatic segments IV–V and VII–VIII. 
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thrombosis, portal hypertension, Budd–Chiari syndrome, peripheral cholangiocarcinoma, and liver failure may result in 
poorer tolerance of the patient to procedure, increased graft loss, and increased costs [62]. 
The  first report of OLT  for PLD was by Kwork and Lewin  in 1988, but  the patient died  intraoperatively of  intractable 
bleeding. In 1990, Starzl successfully performed OLT on 4 patients with PLD. 
OLT  in PLD  is  technically  challenging  because  of  the massive  organomegaly  (Figure  23).  If OLT  is  anticipated  on  a 
patient with PLD,  then any other  surgical  interventions  should be withheld  in order  to avoid massive  intraoperative 
          
Figure 22. CT for a female patient with PLD submitted to laparoscopic fenestration of the largest cysts situated in the
hepatic segments IV–V and VII–VIII. (A) Axial view of the upper liver. (B) Axial view of the lower liver. (C) Sagittal
view of the liver. D. C ronal vi w of the liver.
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The first report of OLT for PLD was by Kwork and Lewin in 1988, but the patient died
intraoperatively of intractable bleeding. In 1990, Starzl successfully performed OLT on 4
patients with PLD.
OLT in PLD is technically challenging because of the massive organomegaly (Figure 23). If
OLT is anticipated on a patient with PLD, then any other surgical interventions should be
withheld in order to avoid massive intraoperative bleeding and thus transfusion requirements.
The anatomic position of the vessels is not respected in patients with PLD. In total hepatectomy,
dissection starts in the liver hilum because it is the only structure that lies at a near-normal
anatomic position. Hepatic artery, portal vein, and principal biliary duct are identified. No
attempt is made to control the suprahepatic vena cava at the beginning of dissection. Early
attempts at controlling it may result in its laceration, fatal bleeding, and pulmonary air
embolism. Patients with PLD have little portal hypertension and spontaneous portocaval
shunts and thus poor tolerance of portal clamping [62]. The surgeons must be prepared for
portal bypass if hypotension develops when portal vein is clamped. Other surgeons system‐
atically use portal bypass. By dissecting portal vein for cannulation, a broad exposure of the
intrahepatic vena cava is obtained. The decision of inferior vena cava resection is made based
on the intraoperative conditions determined during the dissection phase [64]. Some surgeons
choose to continue the dissection of the liver en bloc with the native vena cava and eventually
safely control the suprahepatic vena cava. The en bloc resection of the liver with the native
vena cava is justified by the fact that usually the cava vein is embedded within an extremely
voluminous caudate lobe [62]. There are other surgeons who performed dissection of liver
parenchyma from IVC. Cysts were aspirated to facilitate final access to the suprahepatic
inferior vena cava. However, one should be prepared for vein control through transdiaphrag‐
matic or transsternal approach.
Transcatheter embolization has been proposed to decrease arterial supply of the cysts and thus
reduce the liver size and may be beneficial prior to liver transplantation [65].
Figure 23. Female patient with PLD and ADPKD with indication for liver transplantation. (A) Body topography with
huge abdomen volume. (B) CT, axial view: extensive hepatomegaly with multiple diffuse hepatic cysts entirely occu‐
pying the liver parenchyma. (C) CT, axial view: extensive hepatomegaly with the inferior border of the liver reaching
the pelvis; multiple bilateral kidney cysts with both kidney displaced in the pelvis.




The most frequent complications encountered in the treatment of the simple hepatic cysts are
hemorrhage and infection of the residual cavity. Recurrence of the hepatic cystic mass in the
same location must be differentially interpreted based on the previous treatment, elapsed time
from the treatment, histological type and size of the cyst, and existing symptoms.
In case of early recurrence of the hepatic cystic mass after percutaneous treatment, absence of
malignancy criteria and symptoms, the treatment may vary from simple observation by US
scan to surgical treatment, based on the patient’s consent.
In case of early recurrence of hepatic cystic mass of similar size after percutaneous sclerother‐
apy or laparoscopic fenestration and malignancy criteria absence, the treatment may vary from
percutaneous treatment to open surgery. An intracystic hematoma should be suspected as a
cause of hepatic mass persistence especially when it is associated with inflammatory and/or
internal hemorrhage symptoms. Percutaneous drainage is the first choice in the treatment of
hematoma. In case of active bleeding and/or hemodynamic instability, emergency surgical
intervention is indicated.
If the patient develops symptoms of infection associated with the persistence of hepatic cystic
mass, hepatic abscess should be suspected as a complication and antibiotic treatment should
be initiated empirically followed by further adjustments depending on bacterial cultures. If
the symptoms persist and localization of the abscess permits, the percutaneous drainage is
advisable. If the symptoms do not remit under antibiotics or the percutaneous drainage is not
feasible, the patient must be referred to surgery.
Figure 24. CT for central hepatic serous cyst (segments IV, V VII) (A) with recurrence after 3 months (B), having similar
size and causing the same symptoms to the patient
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In case of late recurrence after laparoscopic or classic fenestration for hepatic cyst, with
documented US follow-up that initially attests the cyst remission, it should be reasonable to
highly consider complete surgical removal of the recurrent cyst even if there are no serologic,
imagistic, or histological criteria of malignancy (Figure 24).
The rate of symptomatic recurrence after percutaneous sclerotherapy is around 20%.
Laparoscopic unroofing or marsupialization can completely relieve symptoms from either
simple lesions or PLD, with the procedure’s morbidity, mortality, and recurrence rates being,
respectively, 2%, 0%, and 2% for patients with simple cysts, and 25%, 0%, and 5% for patients
with PLD. For infected cysts, the procedure of choice is percutaneous drainage, with morbidity,
mortality, and recurrence rates for simple cysts being 0%, 0%, and 75%, respectively, and for
PLD, 0%, 0%, and 20%, respectively [54]. The conversion rate from laparoscopy to laparotomy
is less than 10% [66]. Postoperative morbidity in open deroofing of the hepatic cysts has been
reported to be significantly higher than in laparoscopic procedure (33% versus 13%) but the
difference may reflect the selection of more difficult cases for open surgery [66]. No mortality
is acceptable for surgical therapy of hepatic cysts, unless liver transplantation is considered.
Survival rate after OLT for PLD has been reported as high as 90% [67].
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